ANI Pharmaceuticals | ANIP - Ebit


ANI Pharmaceuticals reported $38.71M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
AbbVie USD 6.72B 1.99B Jun/2026
ANI Pharmaceuticals USD 38.71M 9.58M Mar/2026
Aurora Cannabis CAD 7.12M 42.91M Mar/2026
Canopy Growth CAD -145.65M 132.99M Mar/2026
Eli Lilly USD 12.46B 2.68B Jun/2026
Heron Therapeutics USD 38K 3.83M Dec/2025
Hikma Pharmaceutical USD 348M 31M Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Novartis USD 4.18B 118M Mar/2026
Omeros USD -48.15M 7.25M Sep/2023
Perrigo USD 33.6M 50.8M Mar/2026
Sun Pharmaceuticals INR 35.57B 802.7M Jun/2026
Teva Pharmaceutical Industries USD 235M 523M Jun/2026